As stated, this current IHC analysis used TDP-43 mislocalization as the primary indicator of neurodegenerative disease to determine the pervasive nature of neurodegenerative diseases following a TBI, additional analyses are needed to fully characterize the chronic neurodegenerative effects following a TBI using non-transgenic animal models. Here, TARDBP is linked to neurodegenerative disease.